학술논문
1206P - Phase I evaluation of AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced malignancies
Document Type
Abstract
Author
Source
In Annals of Oncology October 2019 30 Supplement 5:v493-v493
Subject
Language
ISSN
0923-7534